- Home
- Diseases & Health Topics A-Z List
- Candida auris
Candida auris
Candida auris (or C. auris) is a fungus that is causing serious infections in patients in the United States, including New Jersey. C. auris is primarily found in healthcare settings, particularly in long-term acute care hospitals and nursing homes that take care of patients on ventilators. Patients can carry C. auris on their body, even if it is not making them sick. This is called colonization. When people in hospitals and nursing homes are colonized, C. auris can spread from their bodies and can get on other people or nearby objects, allowing the fungus to spread to people around them. In some patients, this fungus can enter the bloodstream and spread throughout the body, causing serious invasive infections. This fungus often does not respond to commonly used antifungal drugs, making infections difficult to treat.
The New Jersey Department of Health responds to all reports of C. auris in New Jersey and supports prevention efforts through surveillance testing and infection prevention recommendations. If C. auris is suspected or identified, contact your local health department and the NJDOH Communicable Disease Service at (609) 826-5964.
New Jersey C. auris Case Count (as of December 1, 2024)
Total case count: 2,281
Confirmed surveillance case count: 1,683
Confirmed surveillance cases are individuals colonized by Candida that have been confirmed as C. auris in the laboratory.
Confirmed clinical case count: 576 (149 of which were surveillance to clinical)
Confirmed clinical cases are individuals with clinical Candida infections that have been confirmed as C. auris in the laboratory.
Probable clinical case count: 22
Probable clinical cases are those with presumptive laboratory evidence and evidence of epidemiologic linkage, and either the isolate was not available for confirmatory testing or has not yet undergone further testing.
Clinical cases (confirmed and probable) of C. auris are based on cultures or culture-independent diagnostic testing from specimens collected during the course of clinical care for the purpose of diagnosing or treating disease. Cases are classified according to definitions established by the Council of State and Territorial Epidemiologists and. National case counts on C. auris is reported by Centers for Disease Control and Prevention (CDC).
Please note: Cases initially identified as surveillance cases that subsequently developed clinical infections are solely reported as clinical cases above in order to avoid double-counting the same individuals.
Resources for Patients and Family Members
- Patient Screening FAQs (CDC) [English] [Spanish] [Korean] [Vietnamese]
- Fact Sheet: Information for Patients about Colonization (CDC) [English] [Spanish]
- Fact Sheet: Information for Patients about Testing (CDC) [English] [Spanish]
- Candida auris Patient FAQs (NJDOH)
- Candida auris Patient Discharge Information (NJDOH)
Resources for Laboratorians and Health Professionals
- What is Candida auris? (NJDOH) [Color] [B&W]
- Recommendations for Laboratorians and Health Professionals (CDC)
- Fact Sheet: Information for Infection Preventionist (CDC) [English] [Spanish]
- Fact Sheet: Information for Laboratory Staff (CDC) [English] [Spanish]
- Case Report Form Completion and Submission Instructions (NJDOH)
- Fundamentals of Infection Control for Candida auris positive patients (NJDOH) [Color] [B&W]
- Infection Prevention and Control Guidance for Providing Care to Individuals with Novel MDROs(NJDOH)
- Transmission Based Precautions for Patients with Novel and Targeted MDROs (NJDOH) [Color] [B&W]
- Cleaning and Disinfection against Candida auris (NJDOH) [Color] [B&W]
- Patient Cohorting (NJDOH) [Color] [B&W]
- Infection Prevention and Control for Candida auris (CDC)
- Candida auris Infection Control Actions for Prevention and Response (CDC)
- Prevention of Invasive Candida auris Infections (CDC)
- Screening for Candida auris (CDC)
- Preventing the Spread of Candida auris (CDC)
- Screening for Colonization in Health Care Facilities (CDC)
- Candida auris Screening Patient Swab Collection (CDC)
- Recommendations for Providing Safe Dialysis Care for Patients with Candida auris (NJDOH)
- General Laboratory Considerations and Recommendations for Candida auris Identification. (NJDOH)
- Laboratory Information for Candida auris Identification (CDC)
- Safety Guidelines for Working with Candida auris Isolates (CDC)
- March 24, 2023: Candida auris: Identification, Reporting and Infection Prevention Guidance Updates
- September 13, 2021: Candida auris: Regional Increase in Cases & Testing Guidance
- July 15, 2021: Candida auris: Cleaning and Disinfection Updates and Mandatory Admissions
- June 2020: Potential Multi-drug Resistant Organisms (MDROs) increase during COVID-19 (SARS-CoV-2) Pandemic
- February 19, 2020: Candida auris in New Jersey
- January 24, 2017: C. auris in New Jersey: Information and Interim Recommendations for Healthcare Facilities and Laboratories
Resources & References
CDC Resources
- CDC Candida auris homepage
- About Candida auris
- Fact Sheet: Candida auris: A Drug-resistant Germ That Spreads in Healthcare Facilities [English][Spanish][Vietnamese] [Korean]
- Clincial Overview of Candida auris (CDC)
- Clinical Care of Candida auris Infections (CDC)
Related NJDOH Links